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Abstract
Hepatitis C virus (HCV), a major cause of chronic liver disease in humans, is the focus of intense research efforts worldwide.
Yet structural data on the viral envelope glycoproteins E1 and E2 are scarce, in spite of their essential role in the viral life
cycle. To obtain more information, we developed an efficient production system of recombinant E2 ectodomain (E2e),
truncated immediately upstream its trans-membrane (TM) region, using Drosophila melanogaster cells. This system yields a
majority of monomeric protein, which can be readily separated chromatographically from contaminating disulfide-linked
aggregates. The isolated monomeric E2e reacts with a number of conformation-sensitive monoclonal antibodies, binds the
soluble CD81 large external loop and efficiently inhibits infection of Huh7.5 cells by infectious HCV particles (HCVcc) in a
dose-dependent manner, suggesting that it adopts a native conformation. These properties of E2e led us to experimentally
determine the connectivity of its 9 disulfide bonds, which are strictly conserved across HCV genotypes. Furthermore, circular
dichroism combined with infrared spectroscopy analyses revealed the secondary structure contents of E2e, indicating in
particular about 28% b-sheet, in agreement with the consensus secondary structure predictions. The disulfide connectivity
pattern, together with data on the CD81 binding site and reported E2 deletion mutants, enabled the threading of the E2e
polypeptide chain onto the structural template of class II fusion proteins of related flavi- and alphaviruses. The resulting
model of the tertiary organization of E2 gives key information on the antigenicity determinants of the virus, maps the
receptor binding site to the interface of domains I and III, and provides insight into the nature of a putative fusogenic
conformational change.
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Introduction
The hepatitis C virus (HCV) is a major cause of chronic liver
disease worldwide, leading to cirrhosis and hepatocellular
carcinoma [1]. In spite of being the focus of intense research
efforts, no vaccine is available against HCV, and current
therapeutic treatments have limited efficacy and significant side
effects [2]. HCV belongs to the Flaviviridae family of enveloped,
positive-strand RNA viruses [3]. Structural studies on this virus are
difficult, in part because it propagates poorly in cell culture, and
particles isolated from infected patients are heterogeneous and not
amenable to a detailed structural characterization. Little structural
information is available on the envelope proteins, which are
heavily glycosylated, display hypervariable loops, and are
stabilized by numerous disulfide bridges [4]. The folding kinetics
of these proteins are slow, requiring several hours for completion
of a complex process involving various ER chaperones of the
infected cell [5]. These properties make their recombinant
production - in a native conformation and in sufficient amounts
for structural studies - a difficult endeavor. Yet structural
information on the HCV envelope proteins would be extremely
valuable, given that they carry the main antigenic determinants of
the virus and play an essential role in cell entry by binding to
specific receptors and inducing membrane fusion. HCV has
indeed been shown to depend on a number of cellular molecules
for entry, including CD81 [6] and the tight junction transmem-
brane proteins claudin 1, 6, 9 and occludin [7–9], as well as the
scavenger receptor B1 (SR-B1) [10]. The LDL receptor also plays
a role in HCV uptake, in line with the observation that HCV
particles in infected plasma are associated with LDL species [11].
PLoS Pathogens | www.plospathogens.org 1 February 2010 | Volume 6 | Issue 2 | e1000762A direct interaction of the HCV envelope protein E2 with CD81
and SR-B1 has been demonstrated, and these interactions were
shown to be necessary but not sufficient for cell entry. The mode of
interaction of HCV with the claudins and occludin is not
understood at present.
The HCV genome codes for a single polyprotein precursor
about 3000 amino acids long, spanning the ER membrane
multiple times. It contains, sequentially, the viral proteins in the
order Nter-C-E1-E2-p7-NS2-NS3-NS4A/B-NS5A/B-Cter. The
N-terminal 1/4
th of the precursor corresponds to the structural
proteins C (Core), E1 and E2 (envelope proteins 1 and 2) and p7,
which functions as a proton channel. The remainder of the
polyprotein contains the non-structural (NS) proteins, which have
enzymatic and other activities that are necessary for virus
replication. The mature viral proteins are generated by proteolytic
processing of the precursor by cellular and viral proteases [3]. In
particular, the envelope proteins are generated by host-cell
signalases. E1 and E2 are type 1 trans-membrane (TM) proteins
with a large N-terminal ectodomain and almost no cytoplasmic
tail. In the best characterized HCV strain H77, E1 and E2 are 192
and 366 amino acids long and contain 6 and 11 potential N-linked
glycosylation sites, respectively. Biochemical studies have shown
that E1 and E2 fold as a heterodimer, which is found at the surface
of viral particles and is thought to be the functional glycoprotein
form [4]. There are currently 6 identified HCV genotypes further
divided into several subtypes [12]. The amino acid sequence
identity between envelope proteins from different genotypes is
about 68% for the most distant genotypes. E2 has been shown to
contain 3 hypervariable regions that can be deleted without
affecting the overall fold of the protein, as assayed by binding to
conformation-sensitive mAbs and CD81 [13–15].
The genomic organization of HCV is characteristic of all
members of the Flaviviridae family [3]. In particular, the envelope
proteins are present in tandem within the polyprotein precursor.
This arrangement of the structural part of the genome is
characteristic of viruses encoding class II fusion proteins, reviewed
in [16]. These proteins have been extensively characterized,
structurally and biochemically, for viruses in the flavivirus genus
within the Flaviviridae family [17]. Class II proteins have a common
tertiary structure, which has also been observed in the fusion
protein of Semliki Forest virus (SFV), an alphavirus belonging to a
separate family of enveloped, positive-strand RNA viruses, the
Togaviridae [18]. Togaviridae and Flaviviridae display the same gene
order in the structural part of their genomes. There is no amino
acid sequence similarity in the alpha- and flavivirus fusion
proteins, however, and in spite of sharing a common fold, they
are stabilized by a different pattern of disulfide bonds. Viruses
within the Flaviviridae families have no sequence similarity across
the various genera either, and the fusion proteins from each genus
also appear to have their own characteristic pattern of disulfide
bonds. Yet the conservation of the class II fold across viral families
in the absence of sequence conservation strongly suggests that it is
also conserved across the different genera within the respective
families.
A further feature of class II viral fusion proteins is that they fold
as a heterodimer with the upstream glycoprotein in the
polyprotein precursor. This heterodimer later dissociates to drive
membrane fusion upon interactions with the host cell. The first
glycoprotein in the tandem thus acts as chaperone for folding the
second one, which has the membrane fusion role. The chaperone
function was experimentally demonstrated for the flavivirus prM
[19] and the alphavirus p62 [20] glycoproteins, which precede the
fusion proteins E and E1, respectively, in the precursor
polyprotein. The effect on folding appears to be reciprocal, since
both p62 and prM also adopt their native conformation only in
presence of the respective accompanying fusion protein (unpub-
lished observations). Importantly, heterodimerization upon folding
has also been characterized for viruses belonging to other genera
in the two families, and in particular for HCV [5,21].
Flavivirus E and alphavirus E1 change into a homotrimer upon
interaction with lipids in the acidic environment of a target cell
endosome, in a process that drives fusion of the viral and
endosomal membrane and results in infection of the cell [22,23].
This process involves homodimer (E-E, flavivirus) or heterodimer
(E2-E1, alphavirus) dissociation, followed by homotrimerization of
E (flavivirus) or E1 (alphavirus) upon binding to lipids. The tertiary
structure of class II viral fusion proteins contains predominantly b-
sheets segregated into three distinct domains arranged linearly,
resulting in a rod-like molecule. The central domain 1 (DI) is a b-
sandwich with two long insertions in loops connecting adjacent b-
strands. These insertions form an elongated ‘‘fusion’’ domain
(DII), carrying the ‘‘fusion loop’’ in the first of the two insertions, at
the distal end of the rod. The fusion loop is a segment of the
polypeptide chain that inserts into the target membrane in the first
step of membrane fusion. At its C-terminal end, DI is connected
via a flexible linker to domain 3 (DIII), which is located at the
opposite side with respect to DII, giving rise to the linear
organization of the molecule. DIII plays an important role in the
fusogenic conformational change, during which it relocates to the
side of the molecule, resulting in the characteristic ‘‘hairpin’’
conformation of the protein, which drives membrane fusion. This
relocation involves a considerable stretching of the segment
connecting DI to DIII, the region that changes most dramatically
in conformation during the fusogenic transition (reviewed in [16]).
Although there is no direct experimental evidence demonstrat-
ing the role of E2 as the HCV fusion protein, the compelling
similarities to viruses with class II fusion proteins suggest that
membrane fusion is at least one of its biological roles. It is worth
noting, however, that while totally unrelated viruses can have
structurally homologous fusion proteins (for example, rhabdovi-
ruses, herpesviruses and baculoviruses, reviewed in [24]), related
viruses can use non-homologous fusion proteins, as is the case with
paramyxoviruses and rhabdoviruses, which belong to the Mono-
negavirales order (reviewed in [25]). Yet the fact that viruses
belonging to different genera in the Flaviviridae and Togaviridae
families display a genomic arrangement that is the signature of
Author Summary
Little is known about the structure of the envelope
glycoproteins of the hepatitis C virus (HCV), in spite of
their essential role in the viral cycle of this major human
pathogen. Here, we determined the connectivity of the 9
disulfide bonds formed by the strictly conserved 18
cysteines of the ectodomain of HCV glycoprotein E2. We
show that this information, together with important
functional data available in the literature, impose impor-
tant restrictions to the possible three-dimensional fold of
the molecule. Indeed, these constraints allow the unam-
biguous threading of the predicted secondary structure
elements along the polypeptide chain onto the template
provided by the crystal structures of related flavi- and
alphavirus class II fusion proteins. The resulting model of
the tertiary organization of E2 shows the amino acid
distribution among the characteristic class II domains,
places the CD81 binding site at the interface of domains I
and III, and highlights the location of a candidate fusion
loop.
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features outlined above, makes it very likely that they code for
envelope glycoproteins that are at least distantly related to class II
proteins.
A model for E2 has actually been proposed based on the
structure of the flavivirus E protein homodimer [26], although no
evidence is available for homodimerization of HCV E2, which
forms a heterodimer with E1 in infectious virions [4]. More
importantly, this model does not take into account the location of
the strictly conserved cysteine residues forming 9 disulfide bonds
[27]. This model also lacks the third domain, which is important in
the fusogenic transition. Moreover, it was also proposed that the
membrane fusion function could be carried by HCV glycoprotein
E1 (i.e., the first glycoprotein in the tandem) [28,29], in spite of the
similarities with flavi- and alphaviruses discussed above, and in the
absence of experimental support. Furthermore, a bioinformatics
model for HCV E1 as a truncated class II protein was reported
[30], postulating that E1 has the fold of DII of an alpha- or
flavivirus fusion protein, but neglecting the fact that in class II
proteins, DII works in conjunction with the other two domains
covalently linked within the polypeptide to induce membrane
fusion. The corollary is that controversial hypotheses have been
reported concerning the identity of the HCV fusion protein. It is
therefore important to stress that the structural studies performed
over the years on viral membrane fusion proteins strongly suggest
that most animal enveloped viruses encode fusion proteins
belonging to one of the three currently characterized structural
classes [31]. It is thus highly unlikely that HCV would have
acquired a totally novel fusion machinery (for instance, one in
which E1 would be the membrane fusion protein), especially when
taking into account the similarities to class II proteins presented
above.
In order to bring more insight into the tertiary structure of HCV
E2, we report here the experimental identification of the
connectivity of the 9 disulfide bonds present in the recombinant
E2 ectodomain (E2e) generated by expression of the E1-E2DTM
portion of the HCV genome in Drosophila S2 cells (Fig. 1A). The
absence of the transmembrane (TM) segment in E2 leads to
secretion of its ectodomain after folding in the presence of E1. This
approach is based on previous results leading to production of
recombinant dengue virus E protein in the presence of its viral
chaperone prM [32]. We tested the conformation of recombinant
HCV E2e biochemically and functionally, showing that it reacts
with conformation-sensitive antibodies and inhibits infection of
Huh7.5 cells by infectious HCV particles (HCVcc) in a dose-
dependent manner. Knowledge of the disulfide bonds, along with
functional data on deletion mutants [14] and CD81 binding
[26,33,34], together with secondary structure predictions, provide
sufficient constraints to reconstitute the tertiary organization of the
molecule. This information allowed the threading of the E2e
polypeptide chain onto a class II template by matching the
predicted b-strands. The resulting model reveals the distribution of
the amino acids of HCV E2 among the different domains, maps
the CD81 binding site to the DI/DIII interface, and highlights a
strictly conserved segment of the polypeptide chain as a strong
candidate for the HCV fusion loop.
Results/Discussion
Biochemical characterization of recombinant E2e
We generated stable Drosophila S2 cell-lines expressing the E1-
E2DTM segment of the precursor polyprotein (Fig. 1A) from 9
isolates spanning all 6 HCV genotypes and 4 subtypes (Table 1). In
order to ensure that the recombinant E2 proteins were functional,
we selected isolates previously tested for entry of retroviral particles
pseudotyped with HCV glycoproteins (HCVpp) with the corre-
sponding sequences [35]. Induction of expression at high cell density
with CdCl2 resulted in accumulation of relatively high levels of
secreted E2e in the cell culture medium. We purified the protein to
homogeneity from the supernatant (described in Text S1), with the
yields listed in Table 1. E2e from the different isolates behaved
similarly, as judged by size exclusion chromatography (SEC)
followed by SDS-PAGE analysis under reducing and non-reducing
conditions and Coomassie blue staining (Fig. 1). In a typical SEC
profile, the majority of the protein elutes at a volume corresponding
to a monomer, with additional minor peaks corresponding to
disulfide linked dimers and higher multimers, which vary depending
on the construct analyzed. The monomeric form was efficiently
separated from the other species by pooling the corresponding
fractions. Analytical ultracentrifugation and small angle X-ray
scattering confirmed the monomeric state of the protein eluted in
these fractions (data not shown). Once isolated, E2e from all
constructs listed in Table 1 remained monomeric and showed no
tendency to associate into disulfide-linked aggregates over time. The
construct corresponding to the genotype 2b isolate (UKN2b_2.8)
reproducibly yielded the highest amounts of purified monomeric
protein (Table 1). The construct from genotype 4 (UKN4_11.1
isolate) yielded a significant fraction of disulfide-linked aggregates
(Fig. 1), which are likely to correspond to misfolded protein. E2e
from the remaining 7 constructs yielded slightly lower yields of
purified, monomeric protein than did the genotype 2b construct, the
lowest yields being from the gentoype 6 isolate (Table 1). The SEC
Figure 1. Production and biochemical characterization of HCV
E2e. A) Schematic diagram of the HCV genome region coding for the
structural proteins and the constructs used to make stable S2 cell
transfectants expressing E2e. MT: inducible metallothionin promoter,
BiP: Drosophila BiP Signal peptide, EK: enterokinase cleavage site, ST:
Strep-Tag. B) Elution profile of E2e from the HCV isolates indicated from
an Sdx200 size exclusion column. Bottom panels: Non-reducing SDS-
PAGE analysis of the eluted fractions. Arrows indicate multimeric (A),
dimeric (D) and monomeric (M) forms of the protein.
doi:10.1371/journal.ppat.1000762.g001
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two chromatograms shown in Fig. 1.
Conformational characterization
Because of the higher production yields, we pursued most of the
biochemical characterization using E2e from genotype 2b, to
which we will refer to as E2e in the rest of the manuscript, except
when explicitly stated. Yet because the best functionally charac-
terized HCV strain is H77 (genotype 1a), we use the amino acid
numbering corresponding to the H77 polyprotein throughout the
manuscript.
Pull-down assays showed that E2e efficiently binds the CD81
large external loop (LEL), as well as conformation-sensitive mAbs
CBH-4B and CBH-4D [36] (Fig. S1A). To further confirm that
CD81 and the conformation-sensitive mAbs bind stoichiometri-
cally to monomeric E2e, we used SEC to analyze the formation of
various E2e/ligand complexes in defined ratios. The resulting
chromatograms display a quantitative shift of the peak from
monomeric protein to an E2e/mAb complex with a 2:1
stoichiometry, as expected (Figs. 2A and S1B). The SEC profile
displayed in Fig. 2 shows the well-characterized conformation-
sensitive mAb H53 that is specific for genotype 1a, whereas Fig.
S1B shows the same analysis of E2e from the genotype 2b isolate
and the human conformation-sensitive mAb CBH-4D. Similarly,
SEC analysis using the Fab fragment of the corresponding mAbs
under the same conditions, yielded a 1:1 E2e/Fab stoichiometry,
as expected (data not shown). SEC analysis revealed that E2e also
forms a stoichiometric complex with the CD81 LEL (data not
shown). The monomeric fraction from all isolates listed in Table 1
yielded similar results - except perhaps for the genotype 6 isolate,
which was not tested - strongly suggesting that recombinant E2e
adopts a conformation closely resembling that of authentic E2
present on virions.
We further tested the ability of E2e to compete with infectious
HCV particles for entry receptors, by measuring its ability to
inhibit infection of Huh-7.5 cells by HCVcc (Fig. 2B). As a control,
we tested in parallel the effect of the flavivirus E protein
ectodomain (sE) from West Nile encephalitis virus (WNV), as well
as the ectodomain of pestivirus E2 (pE2e) from the bovine viral
diarrhea virus (BVDV) produced under identical conditions. In
contrast to the control proteins, HCV E2e exerted a clear dose-
dependent inhibition of the infection. At the lowest concentration
tested (0.05 mM), 10% inhibition was observed, which increased
with protein concentration to reach 90% inhibition at 2 mMo f
HCV E2e. This effect is in line with the observation that E2e
makes a stoichiometric complex with CD81, as described above.
Secondary structure analyses
Computer algorithms for secondary structure prediction using
amino acid alignments of E2 from all 6 HCV genotypes predict
predominantly b-strands in E2e (Fig. 3), consistent with the fold of
class II fusion proteins. We used recombinant E2e to experimen-
tally analyze its secondary structure composition with two
complementary methodologies, circular dichroism (CD), which is
sensitive to the presence of a-helices, and Fourier transform
infrared (FTIR) spectroscopy, which readily detects b-sheets
present in a protein. We carried out these tests in parallel with
recombinant control class II envelope proteins of known structure
available in the laboratory. For the CD measurements, the
controls were WNV sE, ([37], PDB 2I69) and the ectodomain of
glycoprotein E1 (sE1) of Chikungunya virus (CHIKV), which
displays 62.5% amino acid sequence identity with the SFV E1
ectodomain, the crystal structure of which is known ([18], PDB
2Ala). Unexpectedly, the far-UV spectra of the three proteins
exhibited considerable differences (Fig. 4A), the spectrum of HCV
E2e being in agreement with a previous study [38]. However,
deconvolution to retrieve the percentage of the various secondary-
structure elements suggests similar ratios for all three proteins,
indicating, in particular, only about 5% a-helices in all three
proteins. The strong minimum observed at 203 nm in the
spectrum of HCV E2e suggests the presence of natively unfolded
regions that are absent in the control proteins.
Given that circular dichroism is not the most sensitive method
to determine the amount of b-sheet in a protein, we used FTIR
spectrometry in a comparative analysis of E2e with a class II
protein of known 3D structure. Because the WNV sE was not
Table 1. Production yields of E2e constructs from the 9
selected HCV isolates.
Strain/Isolate Genotype Genbank Accession Average Yields *
H77 1a GI:130461 230 mg/l
Con1 1b GI:5420377 180 mg/l
JFH-1 2a GI:116078059 200 mg/l
J6 2a GI:221651 150 mg/l
UKN2b_2.8 2b GI:58198335 300 mg/l
UKN3a_1.28 3a GI:58198337 200 mg/l
UKN4_11.1 4 GI:58198341 190 mg/l
UKN5_14.4 5 GI:58220848 220 mg/l
UKN6_5.340 6 GI:58220846 70 mg/l
*The yields specified correspond to the purified monomeric form of E2e.
Significant differences in production yields (620%) were observed between
independent preparations.
doi:10.1371/journal.ppat.1000762.t001
Figure 2. Functional and conformational characterization of
HCV E2e. A) Stoichiometric complex formation between H77 E2e and
mAb H53. H77-E2e, mAb H53 and a mixture of the two (molar ratio 2:1)
were loaded to the column (in three different runs) (E2e,50kD,
H53,150kD, complex,250kD). No peaks corresponding to either of
the isolated proteins were observed in the profile of the complex,
indicating a 2:1 complex stoichiometry and a high affinity of H77 E2e for
mAb H53. B) Dose-dependent inhibition of infection of Huh7.5 cells by
HCVcc. Huh-7.5 cells were preincubated with increasing concentrations
of HCV E2e, WNV sE or BVDV E2e and subsequently infected with HCVcc
in the corresponding recombinant protein concentration. The number
of infected foci was determined after immunofluorescence analysis
detecting intracellular HCV core antigen. The columns represent mean
values of duplicates in a representative experiment; bars indicate mean
deviation, 100% corresponds to the mean value of the infection in the
presence of the control proteins.
doi:10.1371/journal.ppat.1000762.g002
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dengue virus serotype 3 (DV3), for which the crystal structure is
also known (PDB entry 1UZG [39]). The high-frequency region of
the FTIR spectra of HCV E2e and DV3 sE is displayed in Fig. 4B.
As expected, both proteins have their absorption maxima in the
amide I band at 1637 and 1640 cm
21, respectively, close to the
1630 cm
21 value typical for b-sheet containing polypeptides
(reviewed in [40]), in agreement with the structure of the flavivirus
sE and strongly indicating that HCV E2e also contains
predominantly b-sheets. In order to obtain a quantitative measure
of the b-sheet content of E2e, we performed a further analysis to
more precisely compare the secondary structure content of the two
proteins by computing a difference spectrum after normalization
to an identical area under the amide I band. The DV3/sE –
HCV/E2e difference spectrum showed a positive peak at
1630 cm
21, as well as a broad negative region ranging from
1645 to 1680 cm
21 (Fig. 4B). The value of the positive peak
indicated about 14% higher b-sheet content for DV3 sE, which,
Figure 3. Amino acid sequence alignments and secondary structure predictions. The secondary structure of HCV E2e and alphavirus sE1
was predicted using the program DSC [48], which was selected because the predictions matched more closely the crystallographically determined
secondary structure elements of class II proteins. Arrows or spirals under each sequence indicate predicted b-strands or a-helices, respectively. A) The
main elements of the tertiary structure model of HCV E2 are framed: assigned strands in DI (red, labeled) and DIII (blue), putative fusion loop (yellow),
the stem (grey) and regions that can be deleted without affecting the protein conformation (brown). The 18 cysteines, which form the 9 disulfides,
are marked with arrows and numbered according to the disulfide bond (Table 2) under the sequences. N-linked glycosylation sites are numbered in
green. Residues known to interact with CD81 are marked with small blue circles. The numbering corresponds to the HCV H77 polyprotein. B)
Comparison with a class II fusion protein of known structure. The experimentally determined secondary structure of SFV E1 taken from the crystal
structure (PDB 2ALA, [49]), shown with symbols (arrows or spirals) above the sequence alignment, was compared with secondary structure
predictions for the E1 ectodomain of selected alphaviruses. Experimentally determined b-strands in DI, DII and DIII are colored red, black and blue,
respectively. The red frames indicate the consensus predicted strands in DI, for easier comparison with panel A. Similarly the fusion loop (yellow), the
region corresponding to the crystallographically identified DIII (blue), and the stem (grey) are framed. The 16 cysteines forming the 8 disulfides are
numbered in black according to the disulfide bond under the sequences. The numbering starts with the first amino acid of the E1 glycoprotein.
doi:10.1371/journal.ppat.1000762.g003
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crystal structure, gives about 28% b-sheet for HCV E2e. The
negative area of the difference FTIR spectrum indicates that the
HCV E2e polypeptide displays higher relative amounts of
secondary structure other than b-pleated sheet (random coil, b-
turns, 3/10 helices, etc.). This difference is likely to reflect the
presence of the regions that give rise to the strong minimum at
203 nm in the CD spectrum (Fig. 4A), i.e., natively unfolded
segments of the polypeptide chain.
Disulfide-bond connectivity
We determined the identity of the disulfide bridges by N-
terminal sequencing together with comparative reducing/non-
reducing mass spectrometry analyses of peptides obtained by
trypsin digestion of E2e. For this purpose we selected E2e of three
isolates, UKN2b_2.8, H77 and JFH-1 (genotypes, 2b, 1a and 2a,
respectively), which display amino acid sequences with a different
pattern of predicted trypsin cleavage sites (Fig. S2). We fully
deglycosylated the protein with PNGase F under denaturing
conditions, then digested it with trypsin followed by separation of
the resulting peptides by HPLC under reducing or non-reducing
conditions. Comparison of the HPLC elution profiles enabled the
identification of peaks that were affected by reduction with TCEP
(asterisks in Fig. 5A). We analyzed the samples in these peaks by
surface-enhanced laser desorption/ionization (SELDI) with a
time-of-flight (TOF) spectrometer (Table S1), and identified their
N-terminal sequence by Edman degradation (Fig. S3). This
procedure allowed the unambiguous experimental identification
of 8 out of the 9 disulfide bonds present in the protein, thereby also
identifying the 9
th by exclusion (Table 2). This table also shows
that 5 disulfides were independently identified in at least two
different strains, validating the procedure. A full account of the
experiments made to determine the disulfide connectivity is
provided as Supplementary Information (Text S1).
Implications for the tertiary structure of HCV E2e
The connectivity of the disulfide bonds provides key information
on distant segments of the E2 polypeptide chain that come near
each other in the folded protein. This knowledge can be used in
conjunction with other available data to get a better picture of the
tertiary structure of the protein, namely: i) the observation that
E2e is rich in b-sheet and that secondary structure predictions
suggest regions with consensus b-strands along its amino acid
sequence; ii) the identity of residues that are far apart in primary
structure and that are known to be part of the CD81 binding site;
iii) the postulate that E2 is the HCV fusion protein and therefore
has a characteristic 3-domain class II fold, in agreement with the
organization of its precursor polyprotein, which also implies iv)
that the third domain (DIII) should be connected to DI via a linker
that can extend to stabilize a post-fusion trimer. Finally, DIII
should be followed by a flexible ‘‘stem’’ region - the presence of
which has already been reported for HCV E2 [41] - connecting to
the TM segment. Further information comes from the identifica-
tion of ‘‘hypervariable’’ regions in HCV E2 that can be deleted
without affecting the reactivity of the resulting deletion mutant
with conformation-sensitive mAbs and with CD81 [14]. In
addition, numerous reports have shown that the E2 ectodomain
truncated at position 661, which is in the loop closed by disulfide 9
(Table 2), also reacts with conformation-sensitive mAbs and CD81
[38], suggesting that the downstream segment is not part of the
structured ectodomain.
About one third of the E2e residues are predicted to form b-
strands (Fig. 3), which is in overall agreement with the estimated
28% b-sheet content determined by FTIR spectroscopy. The
pattern of predicted b-strands offers the possibility of threading the
polypeptide chain along the template provided by the known fold
of class II proteins, while simultaneously respecting all of the
known constraints derived for HCV E2 by the functional studies
discussed above. A useful guide for this analysis is the comparison
between predicted and experimentally observed b-strands in the
crystal structure of alpha- and flavivirus fusion proteins - for
instance, in the alphavirus E1 alignment provided in Fig. 3B.
The hallmark of the tertiary structure of class II proteins is the
presence of an 8-stranded (B0 through I0) central domain (or DI)
folded as a b-sandwich with up-and-down topology (Fig. 6). Two
insertions in this domain, in the D0E0 and H0I0 loops, constitute
the fusion domain bearing the fusion loop in the distal part of the
D0E0 insertion. DI is followed, after strand I0, by a flexible
segment connecting to a third domain (DIII), the relocation of
which is important for hairpin formation during the fusogenic
conformational rearrangement of class II fusion proteins.
Threading the HCV E2 polypeptide chain on the tertiary
structure of a class II template
Functional studies have shown that deletion of the HVR1
region did not induce a loss of virus infectivity in experimentally
infected chimpanzees [42], indicating that this segment cannot be
part of a folded domain. We therefore began the threading process
by assigning the 3 consecutive b-strands predicted immediately
Figure 4. Experimental analysis of the secondary structure of
HCV E2e. A) Far-UV CD spectra obtained with recombinant HCV E2e
(empty triangles) and the controls CHIKV sE1 (grey circles) and WNV sE
(black diamonds). The inset shows the estimated fraction of a-helix, b-
sheet, turns and unordered polypeptide chain for the 3 proteins. B) FTIR
spectra of HCV E2e (dashed black line) and DV3 sE (solid black line) and
the difference spectrum of the two after normalization (dashed grey
line) in the amide I band region.
doi:10.1371/journal.ppat.1000762.g004
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conserved strands in the N-terminal part of DI, i.e. B0,C 0 and D0.
These b-strands are followed by a long intervening region that is
compatible with the D0E0 insertion of the class II fold. For the
assignment of strands E0 and F0, the available data on the residues
involved in CD81 binding (small blue circles in Fig. 3) provide
valuable information, since strand E0 must interact with D0 (see
diagram in Fig. 6B). Thus, assigning E0 and F0 to the two
consecutive strands predicted after residue 525 brings together a
patch of residues that are apart in primary structure to the same
face of DI, forming the site of interaction with CD81 (Fig. 6). For
the assignment of the remaining b-strands, there is crucial
information provided by disulfide 1. This disulfide bond connects
Cys429, at the end of strand C0, with Cys552 further downstream,
which therefore must be at the same end of the DI b-sandwich.
This means that Cys552 must be located either at the G0H0 loop,
or at the end of the I0 strand, if the molecule is to have a class II
fold (Fig. 6B). However, after strand F0, there is a long strand
predicted to span residues 549–555 (Fig. 3), which would have
Cys552 in the middle. But the comparison of predicted versus
experimentally determined b-strands of alphavirus E1 shows that,
for several alphaviruses, the region of G0 and H0 is also predicted
as a single long strand (Fig. 3B). Indeed, in both alphaviruses and
HCV, there is a glycine residue (Gly 551 in E2e) forming a tight
turn that reverses the chain orientation, going from G0 into H0
(some alphaviruses have two glycines at this b-turn). This shows
that the prediction algorithms are not 100% reliable, suggesting
that in HCV E2, Gly551 is at the G0H0 turn, and that Cys552 is
the first residue of strand H0. Indeed, running at the edge of the DI
b-sandwich, the sequence of G0 (as well as the sequence of the
alphavirus B0 strand, at the other end of the bottom b-sheet,
Fig. 3B) appears to be less typical than the sequences of internal b-
strands in a b-sheet, which are easier to predict by computer
algorithms. In addition, the short connections between strands F0
through H0 in both alpha- and flavivirus DI are also consistent
with the assignment of H0 to a strand running between residues
552 and 555 in HCV E2.
Having assigned the G0 and H0 strands, additional consid-
erations are necessary to assign strand I0.I na l p h a -a n d
flaviviruses, I0 is one of the two central b-strands of the bottom
sheet of DI, and is directly followed by the linker connecting to
DIII. Because it is the only strand missing to complete the 8-
stranded b-sandwich, it can only make disulfide bonds to
cysteines located upstream in primary sequence. In HCV, three
b-strands are predicted directly downstream to the assigned H0
strand: one around residue 563, one around 573, and one
around 593 (Fig. 3). The strand around residue 573 is part of a
segment that can be deleted without affecting protein confor-
mation [14], indicating that it cannot be I0. The strand around
593 ends at Cys597, which forms disulfide 7 with Cys620
further downstream. Because class II proteins can have no
Figure 5. Disulfide mapping strategy. A) Typical HPLC elution profile of a tryptic digest of E2e under non-reducing (black) and reducing (light
grey) conditions, superposed to highlight the difference in mobility upon reduction. Asterisks mark peaks that disappeared upon reduction and were
thus selected for further proteomic analysis. B) Mass spectrum of a sample recovered from an HPLC peak susceptible to reduction (Peak 16-3 of JFH-1
E2 identified as peptide J4 in the detailed description provided in SI). Upon reduction, a shift in molecular mass of 2Da was observed, due to addition
of two hydrogen atoms upon reduction of the two cysteines. The data presented in this figure allowed the identification of disulfide 4 (Table 2).
doi:10.1371/journal.ppat.1000762.g005
Table 2. Recapitulation of the 9 disulfide bridges and the
isolates in which they were identified.
H77 JFH-1 UKN2b_2.8
1 Cys429 - Cys552 +
2 Cys452 - Cys459 + +
3 Cys486 - Cys494 + +
4 Cys503 - Cys508 + +
5 Cys564 - Cys569 +
6 Cys581 - Cys585 + +
7 (Cys597 - Cys620)
8 Cys607 - Cys644 + + +
9 Cys652 - Cys677 +
doi:10.1371/journal.ppat.1000762.t002
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function - this strand cannot be assigned to I0 either. Indeed, the
interleaved nature of disulfide bonds 7 and 8 dictates that none
of the strands predicted downstream can be in DI. The only
option compatible with a class II fold is, therefore, to assign the
strand around residue 563 to I0. This assignment implies that
the long insertion in the H0I0 loop of the alpha- and flavivirus
fusion proteins is absent in HCV E2. This is in line with E2 from
Figure 6. Tertiary organization of HCV E2e. A) The linear sequence of HCV H77-E2e, numbered every 10 residue according to the polyprotein
(N-terminus at position 384 and the TM region beginning at 716) is represented as a chain of beads (colored circles) labeled with the corresponding
amino acid and threaded onto a class II fold as described in the text. Circles in pale and bright colors represent residues in the background and
foreground of the domains, respectively labeled in white and black fonts. Disulfide bonds and glycosylation sites are indicated by thick black bars and
green circles, respectively, numbered sequentially. Unstructured segments are in white font on a brown background. Residues that participate in
CD81 binding are contoured in blue, and those from the putative fusion loop region in red. In DIII, a plausible arrangement of the 3 predicted b-
strands is illustrated by placing the corresponding polypeptide segments in an antiparallel putative b-sheet, but unlike DI, the topological
arrangement of this domain was not determined. B) Schematic diagram of the tertiary organization of HCV E2, with DI, DII and DIII in red, yellow and
blue, respectively. The stem region is grey. The connectivity of the b-strands in DI is indicated, labeled with the standard class II nomenclature. A
broken yellow line indicates the place of the second insertion in other class II proteins.
doi:10.1371/journal.ppat.1000762.g006
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flavivirus fusion proteins by about 80–110 amino acids, i.e.,
roughly the length of the insertion in the H0I0 loop of the latter.
The assignment of the 8 strands in HCV DI also indicates that
the linker connecting DI and DIII must be between disulfides 5
and 6, encompassing the region called IgVR (‘‘intergenotypic
variable region’’), which can be deleted without affecting protein
conformation, at least in the prefusion form of E2. As discussed
above, the segment containing disulfide 9 is likely not to be part
of the structured ectodomain, further implying that DIII is
comprised between disulfides 6 and 9, spanning about 70 amino
acids. The presence of two long-range disulfide bonds (disulfides 7
and 8) suggests that this region is indeed structured into a
separate domain. However, the secondary structure predictions
point to only 3 b-strands in this domain, indicating that the Ig-
like fold of DIII in alpha- and flaviviruses may not have been
maintained in HCV. Moreover, we found no obvious way to
propose an Ig-like arrangement of the polypeptide chain in this
domain such that it would also satisfy the constraints imposed by
disulfides 7 and 8.
Main features of the teriary structure of HCV E2
The resulting model for the tertiary structure of E2 is presented
in Fig. 6A, with the diagram of Fig. 6B higlighting, as a guide, the
essential features of the resulting ‘‘class II’’ organization of the
protein. The main features of the molecule are the following:
DI
This domain has an N-terminal extension in flaviviruses (which
includes b-strand A0) with respect to alphaviruses (see review by
[16]), and in HCV, the HVR1 also appears to be an N-terminal
extension. DI contains disulfides 1 and 5, both at the DII distal end
of the DI b-sandwich; i.e., at its DIII interacting end. Disulfide 5
connects two consecutive cysteines into a short loop at the end of
strand I0.
The C0D0E0F0 b-sheet (or ‘‘top’’ sheet) contains most of the
determinants of CD81 binding (blue circles in Fig. 6A), and 5 of
the 11 N-linked glycosylation sites of E2 (numbered 1, 2, 3, 6 and
7, Figs. 3 and 6A). In contrast, the B0I0H0G0 b-sheet (or ‘‘bottom’’
sheet) has only site 8 (Asn 556, Fig. 6A), located in the H0I0 loop,
at the site of the long insertion in alpha- and flavivirus fusion
proteins (yellow dotted line, Fig. 6B). The presence of an insertion
in the other class II proteins suggests that there is space at this end
of the barrel for a glycan chain attached to Asn556. Importantly,
glycan 8 was shown to be essential for the correct folding of E2, in
line with the key location in the H0I0 loop in the bottom sheet.
Overall, the distribution of glycans on HCV DI is compatible with
the experimentally determined orientation of flavivirus E and
alphavirus E1 at the virion surface, with the bottom sheet facing
the viral membrane. This pattern provides additional evidence
validating our assignment of the DI b-strands.
DII
This domain has two predicted glycosylation sites and three
disulfide bonds (2, 3 and 4), all connecting consecutive cysteine
residues very close in primary structure. In the alpha- and
flavivirus counterparts, the two insertions forming DII are quite
intertwined, and the second one (the H0I0 insertion) acts as a
scaffold supporting the D0E0 insertion bearing the fusion loop at
the DI-distal end. In HCV E2, the absence of the second insertion
makes DII much smaller, and apparently also results in a more
flexible, or disordered domain, as suggested by the absence of
long-range disulfide bonds and the fact that the whole area
between disulfides 2 and 3 can be eliminated without affecting the
overall conformation of the molecule.
A putative fusion loop
The proposed tertiary organization of E2 provides a prediction
for the location of the HCV E2 fusion loop, which in class II
fusion proteins is a stretch of highly conserved residues within the
D0E0 insertion. This segment is composed mainly of non-charged
residues, and is rich in glycine and non-polar amino acids. The
sequence alignment highlights the region spanning residues 502–
520 (red circles in Fig. 6A), which has similar characteristics and
is strictly conserved within all HCV genotypes (Fig. 3). This
region is thus a strong candidate for fulfilling the role of the HCV
fusion loop. The smaller conserved block between residues 484–
489 has been tested by site directed mutagenesis using retroviral
particles pseudotyped with the HCV envelope proteins (HCVpp),
suggesting that it does not play a role in membrane fusion [29].
Because in all class II fusion proteins, the fusion loop is buried at
an oligomeric interface in the prefusion form, the candidate
fusion loop segment is also very likely to mark a contact region
with E1.
Linker region and DIII
Our model predicts that DIII (blue), which in alpha- and
flavivirus fusion proteins has an Ig-like fold, contains disulfides 6, 7
and 8, and the last two glycosylation sites, 10 and 11. It is
connected to the C-terminal end of DI via the IgVR, which
contains glycan 9. This linker region is such that it can be
extended to allow the translocation of DIII to the side of the trimer
during the fusogenic conformational change, as expected for a
class II fusion protein. Yet this segment, located between disulfides
5 and 6 (highlighted in brown in Fig. 6A), can also be replaced by
a GSSG linker without affecting the overall protein conformation
[14], suggesting close apposition between DI and DIII at least in
the prefusion form. This organization is also compatible with the
observation that some of the residues important for CD81 binding
map to DIII (613–618, Figs. 3 and 6), suggesting that CD81
bridges the surface of the two domains. Indeed, these two domains
display an extended interaction surface in other class II fusion
proteins.
The stem region
DIII is followed in sequence by a relatively flexible but
conserved region, denoted the ‘‘stem’’ (grey in Fig. 6), which
connects to the TM segment. The stem would contain a loop that
is closed by the last disulfide (number 9). A number of reports on
the characterization of a protein ending at position 661 indicate
that the absence of this loop does not affect the conformation of
the protein and it is therefore not part of DIII. Further support for
this interpretation is provided by our identification of a trypsin-
resistant fragment of E2e ending at position Arg648, in between
disulfides 8 and 9 (data not shown).
Implications of the tertiary structure model of HCV E2
One important implication is that the residues interacting with
CD81 are found in two domains, DI and DIII, which have to
move apart during the fusogenic conformational change. This
suggest that CD81 may have to dissociate away for such a
conformational change to take place, or on the contrary, that its
binding may help to lower the energy barrier for the conforma-
tional change to occur upon exposure to low pH in the endosomes.
An additional information from this study is the positioning of
the hypervariable regions of HCV E2 in the context of the class II
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be responsible for the difference in CD spectrum between HCV
E2e and the other class II proteins examined (Fig. 4A), which do
not contain unstructured regions. Such regions are presumably
important for evading the humoral immune response of the host,
given that HCV can cause chronic infection, in contrast to alpha-
and flaviviruses. Another important difference to the latter are the
numerous glycosylation sites in HCV E2. Our model indicates that
these sites cluster in particular on the exposed face of DI. Indeed,
several glycans appear to frame the CD81 binding surface,
partially shielding it from recognition by circulating antibodies.
These are glycans 1, 2, 6, 7, and possibly 10 and 11 (Fig. 6A).
Importantly, a number of studies have pointed to a role of some of
these E2 glycosylation sites modulating entry and/or CD81
binding [43,44].
Another important implication is the identification of a strong
candidate region for the fusion loop. This polypeptide segment,
spanning residues 502–520 of E2, has all the characteristics
reported for the experimentally characterized class II fusion
loops. It is strictly conserved, and is located in a region of the
protein that is compatible with this function – in the D0E0
insertion of DI - in spite of being part of a fusion domain (DII)
that is much smaller than its alpha - and flavivirus counterpart.
The fact that in the latter DII is formed by two insertions into a
simple, conserved DI, suggests that they may have evolved
sequentially. HCV may have thus maintained some ancient
intermediate form of the class II proteins, containing only the
insertion that carries the fusion loop.
The observed flexible and largely unstructured conformation of
DII is likely to be due to the absence of the H0I0 scaffold. The
presence of the candidate HCV fusion loop relatively close to DI is
another important difference. In the alpha- and flavivirus
counterparts, there are about 30 intervening residues present in
an extended conformation between the fusion loop and strand E0,
whereas there are only a few residues in HCV. This difference is
likely to be related to the intrinsic flexibility of HCV DII, since the
fusion loop is unlikely to lie at the distant tip of an unstructured
domain. During membrane fusion, the fusion loop could be
further stabilized by interaction with the membrane proximal
region of the stem, once the molecule adopts its fusogenic hairpin
conformation. This organization also suggests a significantly
shorter post-fusion HCV E2 trimer, compared to the other class
II proteins. This would be analogous to the observed differences in
the post-fusion trimers of class I viral fusion proteins, for instance
from retroviruses, which are short [45], and paramyxoviruses [46]
or coronaviruses [47], which display a very long hairpin
conformation.
Overall, our model for the HCV E2 tertiary organization
provides a structural framework to understand the antigenicity of
the virion, the organization of the regions that interact with CD81,
and the putative conformational changes that are likely to take
place during the membrane fusion reaction to invade a target cell.
In the absence of 3D structural data, our results constitute an
important step to better understand the function of the HCV
envelope proteins. This knowledge, in turn, can help devise
possible antiviral strategies against this important pathogen. Our
data also provide a handle to dissect and obtain structural data on
the E2 domains separately, given that the intact ectodomain is
very difficult to crystallize.
Finally, this analysis highlights the power of conducting parallel
structural studies on related viruses, which provide information
that can be extrapolated to other members of the respective viral
families, even in the absence of sequence similarity in the
corresponding proteins.
Materials and Methods
The accompanying Supplementary Information (Text S1)
describes in detail the construction of the vectors used for
expression of synthetic genes coding for the E1-E2DTM segment
of the 9 HCV isolates tested (Table 1), the protocols for
production, purification and conformational characterization of
recombinant HCV E2e, as well as the computer and experimental
analyses used for secondary structure predictions. Finally, a
detailed description of the procedures used for the experimental
identification of the cysteine residues involved in 8 disulfide bonds
of E2 is provided.
Supporting Information
Text S1 Supplementary materials and methods
Found at: doi:10.1371/journal.ppat.1000762.s001 (0.15 MB PDF)
Table S1 Identification of disulfide bond connected HCV E2e
peptides resulting from tryptic digest
Found at: doi:10.1371/journal.ppat.1000762.s002 (0.05 MB PDF)
Figure S1 Conformational characterization of HCV E2e. A)
Pull-down experiment showing that E2e specifically reacts with
conformation dependent antibodies CBH-4B and CBH-4D, but
not a control antibody, and binds the CD81 LEL. E2e was affinity
loaded onto a Streptactin column, samples containing the
respective proteins were passed through the column and the
complex was eluted after washing. Elution fractions were analysed
by SDS-PAGE under reducing conditions. Bands representing the
E2e, CD81-LEL as well as the heavy chain (HC) and light chain
(LC) of the two antibodies were observed. B) Stoichiometric
complex formation between UKN2b_2.8 E2e and mAb CBH4D.
UKN2b_2.8 E2e, mAb CBH4D and a mixture of the two (ratio
2:1) were loaded to the column (in three different runs)
(E2e,50kD, H53,150kD, complex,250kD). No peaks corre-
sponding to either of the isolated proteins were observed in the
profile of the complex, indicating a 2:1 complex stoichiometry and
a high affinity of UKN2b_2.8 E2e for mAb CBH4D.
Found at: doi:10.1371/journal.ppat.1000762.s003 (1.23 MB TIF)
Figure S2 Alignment of HCV E2 amino acid sequences from
strains H77, JFH-1 and UKN2b_2.8. Given the deamination of
Asn residues by PNGase F, they are turned into Asp residues.
Predicted trypsin cleavage sites (grey triangles) and N-glycosylation
sites (empty diamonds) are indicated, cysteines are boxed and the
respective disulfide bridges displayed (-SS-). Peptides identified
after tryptic cleavage are shaded, named according to the
respective isolate and numbered sequentially following the amino
acid sequence of E2.
Found at: doi:10.1371/journal.ppat.1000762.s004 (2.52 MB TIF)
Figure S3 Proteomics results for the determination of the
disulfide bridges. HPLC chromatogram peaks that were selected
for further proteomics analysis. Results of N-terminal sequencing
and SELDI-TOF MS for the respective peaks are shown in panels
A-G. Scales for the intensity (y-axis) as well as for the molecular
weight (x-axis) vary considerably in the different spectra, resulting
in a different appearance of the background noise. A) Peaks JFH-1
6-3 and 12-3, leading to the identification of disulfide bridges 2
(peak 6-3) and 8 (peak 12-3) in E2e of JFH-1. B) Peak JFH-1 16-3,
leading to the identification of disulfide bridge 4 in E2e of JFH-1.
C) Peaks UKN2b_2.8 13-1 and 20-1, leading to the identification
of disulfide bridges 2 (peak 20-1) and 8 (peak 13-1) in E2e of
UKN2b_2.8. D) Peaks UKN2b_2.8 42-3 and 19-1, leading to the
identification of disulfide bridges 1 (peak 42-3) and 6 (peak 19-1) in
E2e of UKN2b_2.8. E) Peaks H77 15-2 and 6-2, leading to the
Disulfide Connectivity Pattern of HCV E2
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E2e of H77. F) Peaks H77 26-2, which is the result of disulfide
shuffling, and 32-2, leading to the identification of disulfide bridge
3 in E2e of H77. G) Peaks H77 43-2 and 33-2, leading to the
identification of disulfide bridges 5 (peak 33-2) and 9 (peak 43-2) in
E2e of H77.
Found at: doi:10.1371/journal.ppat.1000762.s005 (6.93 MB TIF)
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